Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control
CGM
1 other identifier
interventional
22
1 country
1
Brief Summary
The study team will assess "free-living" 24h glucose control using continuous glucose monitors (CGM) over an 88h period on two separate occasions. Importantly, standardized meals will be provided and will be consumed at specific times each day of the CGM measurement period. These meals will be identical on day 1 and day 3 of measurement. Each subject will complete two CGM periods, which will be identical except for the calorie and macronutrient content of the post-exercise dinner. In addition, during trial 1, two CGM's will be worn, while only 1 CGM will be worn on trial 2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 21, 2016
CompletedFirst Submitted
Initial submission to the registry
November 13, 2017
CompletedFirst Posted
Study publicly available on registry
November 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2017
CompletedMarch 21, 2022
March 1, 2022
1.2 years
November 13, 2017
March 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Average Post-prandial glucose values
Average Post-prandial glucose values (1 hour, 2 hour, and 3 hours) will be measured
1 week
area under curve Post-prandial glucose values (1 hour, 2 hour, and 3 hours)
1 hour, 2 hour, and 3 hours time-point for Post-prandial glucose values will be measured
1 week
Secondary Outcomes (3)
24 hour glycemic response
1 day
Area under curve - 24 hour glycemic response
1 day
CGM Sensor Variability when measured simultaneously
1 week
Study Arms (2)
Trial 1
EXPERIMENTALSubjects will have two CGM devices placed on either side of the abdomen, near the belly button. Trial 1 Exercise - subjects will use a mouthpiece and nose clip (which will allow all of their expired air to pass through the metabolic cart for analysis of oxygen consumption and carbon dioxide production) for \~5 min at the beginning, middle and toward the end of exercise to verify they are exercising at 65% of VO2peak. This will allow us to accurately measure energy expenditure (kcal) during exercise. One hour after the exercise session, participants will eat a standardized dinner which includes the energy expended from their exercise session (+ 350 kcal).
Trial 2
EXPERIMENTALSubjects will have one CGM device placed on one side of the abdomen. Trial 2 Exercise - subjects will exercise at 65% of VO2peak. One hour after the exercise session, participants will eat a standardized dinner which will NOT include the energy expended from their exercise session (- 350 kcal).
Interventions
During the exercise session, subjects will exercise at 65% of VO2peak. One hour after the exercise session, participants will eat a standardized dinner which will NOT include the energy expended from their exercise session (- 350 kcal).
During the exercise session, subjects will use a mouthpiece and nose clip (which will allow all of their expired air to pass through the metabolic cart for analysis of oxygen consumption and carbon dioxide production) for \~5 min at the beginning, middle and toward the end of exercise to verify they are exercising at 65% of VO2peak. This will allow us to accurately measure energy expenditure (kcal) during exercise. One hour after the exercise session, participants will eat a standardized dinner which includes the energy expended from their exercise session (+ 350 kcal).
Eligibility Criteria
You may qualify if:
- Age: 18-40
- Body Mass Index: 20-30 kg/m2
You may not qualify if:
- Pregnant or lactating
- Evidence/history of cardiovascular or metabolic disease
- Medications known to affect glucose metabolism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey F Horowitz
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Movement Science, School of Kinesiology
Study Record Dates
First Submitted
November 13, 2017
First Posted
November 22, 2017
Study Start
October 21, 2016
Primary Completion
December 18, 2017
Study Completion
December 18, 2017
Last Updated
March 21, 2022
Record last verified: 2022-03